LAC 49:I.1163 – Misbranding, Ingredients Designation [Formerly 49:4.0310]

A. A drug shall be deemed to be misbranded if it is not designated solely by a name recognized in an official compendium, unless its label bears:
1. the common or usual name of the drug, if such there be; and
2. in case it is made from two or more ingredients, the common or usual name of each active ingredient, including the quantity, kind and proportion of any alcohol, ana also including, whether active or not, the name and quantity or proportion of any bromides, ether, chloroform, acetanilid, acetphenetidin, amidopyrine, antipyrine, atropine, hyoscine, hyoscyamine, arsenic, digitalis, digitalis glycosides, mercury, ouabain, strophanth in, strychnine, thyroid, or any derivative or preparation of any such substances contained therein: Provided, that to the extent that compliance with the requirements of Paragraph 2 of this Subsection is impracticable, exemptions shall be as provided by §1186.

AUTHORITY NOTE: Promulgated in accordance with Louisiana Revised Statutes of 1950, Title 40, as amended.

HISTORICAL NOTE: Adopted by the Department of Health and Human Resources, Office of Preventive and Public Health Services, September 1968.